Skip to main content

Displaying 265 - 276 of 2274

All Star Charts Premium

Under the Hood (02-05-2024)

February 6, 2024

From the Desk of Steve Strazza @Sstrazza.

Welcome back to Under the Hood, where we'll cover all the action for the week ended February 2, 2024. This report is published bi-weekly, in rotation with The Minor Leaguers.

What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.

We use a variety of sources to generate the list of most popular names.

There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.

All Star Charts Premium

International Hall of Famers (02-02-2024)

February 2, 2024

From the desk of Steve Strazza @Sstrazza

Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs.

We've also sprinkled in some of the largest ADRs from countries that did not make the market cap cut. 

These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.

It's got all the big names and more–but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.

The beauty of these scans is really in their simplicity.

We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.

Based on the market environment, we can also flip the scan on its head and filter for weakness.

Let's dive in and take a look at some of the most important stocks from around the world.

Here's this week's list:

Director Katabi Reports a $5 Million VERA Purchase

February 2, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Maha Katabi, director of Vera Therapeutics $VERA.

Katabi reported a purchase of 161,290 VERA shares, equivalent to $5 million.

All Star Charts Premium

Junior Hall of Famers (02-01-2024)

February 1, 2024

From the Desk of Steve Strazza @Sstrazza

We love our bottoms-up scans here at All Star Charts. We tend to get really creative when making new universes as we want to be sure they will deliver us the best opportunities the market has to offer.

However, when it comes to our latest project, it couldn't be any simpler!

With the goal of finding more bullish setups, we have decided to expand one of our favorite scans and broaden our regular coverage of the largest US stocks.

Welcome to The Junior Hall of Famers.

This scan is composed of the next 150 largest stocks by market cap, those that come after the top 150 and are thus covered by the Hall of Famers universe. Many of these names will someday graduate and join our original Hall Of Famers list. The idea here is to catch these big trends as early on as possible.

There is no need to overcomplicate things. Market cap is a quality filter at the end of the day. It only grows if price is rising. That's good enough for us.

All Star Charts Premium, 2 to 100 Club

2 to 100 Club (01-31-2024)

January 31, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach.

It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

GSK Reports $16.5 Million of WVE Purchases

January 31, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by GSK plc.

The British multinational pharmaceutical company reported a purchase of $16.5 million in Wave Life Sciences Ltd $WVE.

Cathie Wood's ARK Is Loading Biotech Stocks

January 30, 2024

From the Desk of Steve Strazza and Alfonso Depablos

Cathie Wood’s ARK Investment Management is on our list today, as it just filed multiple 13G filings on the following stocks:

  • Teladoc Health, Inc $TDOC, increasing its ownership stake from 11.43% to 12.82%;
  • Intellia Therapeutics, Inc $NTLA, increasing its ownership stake from 10.52% to 12.74%;
  • Recursion Pharmaceuticals, Inc $RXRX, initiating a 9.92% stake;
  • Verve Therapeutics, Inc $VERV, increasing its ownership stake from 5.43% to 8.84%;
  • Ginkgo Bioworks Holdings, Inc $DNA, increasing its ownership stake from 8.92% to 12.26%; and
  • Twist Bioscience Corp $TWST, increasing its ownership stake from 11.60% to 12.51%.

All Star Charts Premium

The Minor Leaguers (01-29-2024)

January 29, 2024

From the Desk of Steve Strazza @Sstrazza

Welcome to The Minor Leaguers.

We've had some great trades come out of this small-cap-focused column since we launched it back in 2020 and started rotating it with our flagship bottom-up scan, Under the Hood.

For the first year or so, we focused only on Russell 2000 stocks with a market cap between $1 and $2B.

That was fun, but we wanted to branch out a bit and allow some new stocks to find their way onto our list.

We expanded our universe to include some mid-caps.

To make the cut for our Minor Leaguers list now, a company must have a market cap between $1 and $4B.

CEO Sabo Reports a $2 Million CODI Purchase

January 29, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a series of Form 4 filings by Elias Sabo, director and CEO of Compass Group Diversified Holdings LLC $CODI.

Sabo reported an aggregate CODI purchase worth roughly $2 million.